Yep. Correct on all fronts. I didn't mention CUV to cross promote. I was asked to provide an example of another biotech company of a similar vintage to SPL which had performed much better in the same period. CUV came to mind as a fair example.
Why are you here, page-18
-
- There are more pages in this discussion • 8 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add SPL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
9.8¢ |
Change
0.001(1.03%) |
Mkt cap ! $40.90M | |||
| Open | High | Low | Value | Volume |
| 9.9¢ | 10.5¢ | 9.7¢ | $22.92K | 232.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 236173 | 9.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 10.0¢ | 50800 | 2 |
View Market Depth
| Last trade - 16.10pm 18/09/2024 (20 minute delay) ? |
| SPL (ASX) Chart |